3-rx.comCustomer Support
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics

\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>

Join our Mailing List


You are here : 3-RX.com > Home > Drug News - Pregnancy - Psychiatry / Psychology -

Drop in antidepressant use seen during pregnancy

Drug News • • Pregnancy • • Psychiatry / PsychologyOct 03, 07

A marked fall in antidepressant use occurs when women first learn that they are pregnant, according to a report.

“It is alarming to see that there is still a fear regarding antidepressant use during pregnancy. We knew that some women were going to discontinue using their antidepressants during pregnancy but we didn’t think it would be so prevalent and inappropriately used (amongst those who remain on it),” senior author Dr. Anick Berard told Reuters Health.

“The risks of untreated depression during pregnancy are significant,” Berard, from the CHU Sainte-Justine Hospital in Montreal, said. “Given the safety of most antidepressants during pregnancy, a careful evaluation of the risk/benefit ratio should be done before deciding to discontinue their use. Although physicians and women think they are protecting their unborn child, they might be doing just the contrary.”

The study included 97,680 women in Quebec who were pregnant between 1998 and 2002. Of these women, 6427 (6.6 percent) were antidepressant users in the 12 months prior to the first day of gestation. In the 12 months after the end of pregnancy, however, the prevalence climbed to 7.0 percent, significantly higher than the prepregnancy rate.

During the first trimester of pregnancy, the prevalence of antidepressant use fell to 3.7 percent. Moreover, antidepressant doses below those recommended were used 7.7 percent of the time and 4.7 percent of patients switched to a different class of antidepressants.

Some of the predictors of antidepressant use during pregnancy included older age of the mom-to-be, living on welfare, having at least two different prescribers, and having at least one diagnosis of depression in the year before pregnancy.

In a related editorial, Dr. V. O’Keane and Dr. M. S. Marsh, from King’s College Hospital in London, comment that “the new evidence…suggests that depression is probably seriously under treated during pregnancy is alarming in terms not only of the costs that the mother will pay as she enters the challenges of motherhood in a compromised manner but also the costs that the baby may have to carry for the rest of its life.”

SOURCE: BJOG: An International Journal of Obstetrics and Gynecology, Sept. 2007.

Print Version
comments powered by Disqus

  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  Anxiety increases the risk of gastrointestinal infection and long-term complications
  New drug for neuroblastoma shows promise in phase I study
  Drug prevents passage of HBV during pregnancy
  Baclofen shows promise in patients with alcohol-induced liver disease
  BGI study confirms accuracy of its NIFTY in nearly 147,000 pregnancies
  How negative stereotyping affects older people
  Findings point to an ‘off switch’ for drug resistance in cancer
  Siblings of children with autism can show signs at 18 months
  Exploring the connection between empathy, neurohormones and aggression
  Stopping statins may benefit terminally ill patients


Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site